BioCentury | Oct 20, 2017
Finance

Stars align for rare AMD

...added other undisclosed technologies or programs from the University of Edinburgh , Newcastle University, and Sanquin Blood Supply Foundation...
BioCentury | Mar 10, 2017
Company News

Sanquin Blood Supply, Synthon deal

...disclose details. Sanquin Blood Supply Foundation, Amsterdam, the Netherlands Synthon B.V. , Nijmegen, the Netherlands Business: Cancer Alicia Parker Synthon B.V. Sanquin Blood Supply Foundation...
BioCentury | Dec 10, 2012
Emerging Company Profile

Xenikos: Dual attack in GvHD

...Nijmegen Corporate partners: None Number of employees: 5 Funds raised: €3.6 million ($4.7 million) Investors: Sanquin Blood Supply Foundation...
BioCentury | Jun 25, 2012
Financial News

Xenikos completes venture financing

...Netherlands Business: Transplant Date completed: 6/19/12 Type: Venture financing Raised: €3.6 million ($4.6 million) Investors: Sanquin Blood Supply Foundation...
BioCentury | Jun 20, 2012
Financial News

Xenikos raises EUR 3.6 million

...Nijmegen, the Netherlands) raised EUR 3.6 million ($4.6 million) in a series A round from Sanquin Blood Supply Foundation...
BioCentury | Mar 21, 2011
Finance

Highlights of weekly biotech stock moves

...hereditary angioedema (HAE). However, CHMP said it considers ViroPharma to be the same applicant as Sanquin Blood Supply Foundation...
BioCentury | Mar 21, 2011
Clinical News

Cinryze regulatory update

...to allow for self-administration of the complement 1 (C1) esterase inhibitor. ViroPharma has rights from Sanquin Blood Supply Foundation...
BioCentury | Mar 19, 2011
Company News

CHMP rebuffs Vectibix expansion, backs Cinryze, apixaban

...treat and prevent angioedema attacks in patients with hereditary angioedema (HAE). ViroPharma has rights from Sanquin Blood Supply Foundation...
BioCentury | Mar 15, 2010
Company News

Biocompatibles, Celsion, Cortius B.V., Glycostem Therapeutics, ISA Pharmaceuticals, IQ Corp. B.V., Percuros B.V., Biomedical Materials, Center for Translational

...blood stem cell homing and engraftment using liposome-complexed Wnt and molecular imaging. For influenza, the Sanquin Blood Supply Foundation...
BioCentury | Feb 18, 2010
Targets & Mechanisms

Transferrin, not transfusions

...Hebrew University of Jerusalem and Sanquin Oy, the Finland-based research subsidiary of the not-for-profit organization Sanquin Blood Supply Foundation...
...Montefiore Medical Center , New York, N.Y. New York Blood Center , New York, N.Y. Sanquin Blood Supply Foundation...
Items per page:
1 - 10 of 18
BioCentury | Oct 20, 2017
Finance

Stars align for rare AMD

...added other undisclosed technologies or programs from the University of Edinburgh , Newcastle University, and Sanquin Blood Supply Foundation...
BioCentury | Mar 10, 2017
Company News

Sanquin Blood Supply, Synthon deal

...disclose details. Sanquin Blood Supply Foundation, Amsterdam, the Netherlands Synthon B.V. , Nijmegen, the Netherlands Business: Cancer Alicia Parker Synthon B.V. Sanquin Blood Supply Foundation...
BioCentury | Dec 10, 2012
Emerging Company Profile

Xenikos: Dual attack in GvHD

...Nijmegen Corporate partners: None Number of employees: 5 Funds raised: €3.6 million ($4.7 million) Investors: Sanquin Blood Supply Foundation...
BioCentury | Jun 25, 2012
Financial News

Xenikos completes venture financing

...Netherlands Business: Transplant Date completed: 6/19/12 Type: Venture financing Raised: €3.6 million ($4.6 million) Investors: Sanquin Blood Supply Foundation...
BioCentury | Jun 20, 2012
Financial News

Xenikos raises EUR 3.6 million

...Nijmegen, the Netherlands) raised EUR 3.6 million ($4.6 million) in a series A round from Sanquin Blood Supply Foundation...
BioCentury | Mar 21, 2011
Finance

Highlights of weekly biotech stock moves

...hereditary angioedema (HAE). However, CHMP said it considers ViroPharma to be the same applicant as Sanquin Blood Supply Foundation...
BioCentury | Mar 21, 2011
Clinical News

Cinryze regulatory update

...to allow for self-administration of the complement 1 (C1) esterase inhibitor. ViroPharma has rights from Sanquin Blood Supply Foundation...
BioCentury | Mar 19, 2011
Company News

CHMP rebuffs Vectibix expansion, backs Cinryze, apixaban

...treat and prevent angioedema attacks in patients with hereditary angioedema (HAE). ViroPharma has rights from Sanquin Blood Supply Foundation...
BioCentury | Mar 15, 2010
Company News

Biocompatibles, Celsion, Cortius B.V., Glycostem Therapeutics, ISA Pharmaceuticals, IQ Corp. B.V., Percuros B.V., Biomedical Materials, Center for Translational

...blood stem cell homing and engraftment using liposome-complexed Wnt and molecular imaging. For influenza, the Sanquin Blood Supply Foundation...
BioCentury | Feb 18, 2010
Targets & Mechanisms

Transferrin, not transfusions

...Hebrew University of Jerusalem and Sanquin Oy, the Finland-based research subsidiary of the not-for-profit organization Sanquin Blood Supply Foundation...
...Montefiore Medical Center , New York, N.Y. New York Blood Center , New York, N.Y. Sanquin Blood Supply Foundation...
Items per page:
1 - 10 of 18